979-32-8
- Product Name:Estradiol valerate
- Molecular Formula:C23H32O3
- Purity:99%
- Molecular Weight:
Product Details;
CasNo: 979-32-8
Molecular Formula: C23H32O3
Appearance: Na
Buy High Quality 979-32-8 In Medicine In Stock In Bulk Supply
979-32-8 Chemical & Physical Properties |
|
Melting point |
144°C |
Boiling point |
486.2±45.0 °C at 760 mmHg |
Density |
1.1±0.1 g/cm3 |
Molecular Formula |
C23H32O3 |
Molecular Weight |
356.498 |
Flash Point |
191.1±21.5 °C |
PSA |
46.53000 |
LogP |
6.62 |
Exact Mass |
356.235138 |
Vapour Pressure |
0.0±1.3 mmHg at 25°C |
Index of Refraction |
1.568 |
storage temp. |
Sealed in dry,Room Temperature |
solubility |
Practically insoluble in water, soluble in alcohol. |
Export Hot Selling High Purity Estradiol Valerate, Fast Delivery
Estradiol valerate (EV) is White to off-white crystalline powder, odorless. Insoluble in water, easily soluble in ethanol, acetone, chloroform, slightly soluble in vegetable oil. Estradiol valerate is a hormone that is utilised in the treatment of a variety of conditions, including transgender women, menopausal symptoms, low oestrogen levels, and hormonal birth control. It is used to reduce symptoms of menopause which are vaginal dryness, hot flashes, and others. Estradiol valerate is commercially available as an intramuscular injection. Estradiol valerate (EV) has been developed to reduce the effects on the coagulation system and lower the VTE risk.
InChI:InChI=1/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18?,19?,20?,21-,23-/m0/s1
979-32-8 Relevant articles
Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis
Annina Haverinen, Kaisu Luiro, Marika H Kangasniemi, Terhi T Piltonen, Steinar Hustad, Oskari Heikinheimo, Juha S Tapanainen
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 7, July 2022, Pages e3008–e3017
To compare estradiol valerate (EV) + dienogest (DNG), EE + DNG, and DNG alone (active control) on levels of follicle stimulating hormone (FSH), luteinizing hormone, anti-Müllerian hormone (AMH), ovarian steroids, sex hormone binding globulin (SHBG), and the free androgen index (FAI).
Effects of 24-hour oral estradiol-valerate administration on hormone levels in men and pre-menopausal women
G Rune, G Joue, T Sommer
Psychoneuroendocrinology, 2023
A large body of evidence has been collected in animal experiments on the manifold effects of 17β-estradiol (E2) mainly in the hippocampus, but also in the prefrontal cortex and on the dopaminergic system, with observable changes in behavior (Luine, 2014, Taxier et al., 2020).
979-32-8 Process route
- 63042-28-4
estradiol divalerate
- 979-32-8,25918-99-4,300853-47-8
estradiol 17-valerate
Conditions | Yield |
---|---|
With methanol; sodium tetrahydroborate; at 40 - 45 ℃; for 2h;
|
74% |
With sodium tetrahydroborate; In methanol; at 40 - 45 ℃; for 2h;
|
74% |
With sodium hydroxide;
|
|
With methanol; potassium carbonate; at 20 ℃;
|
- 63042-21-7
3-benzoyloxy-17β-valeryloxy-estra-1,3,5(10)-triene
- 979-32-8,25918-99-4,300853-47-8
estradiol 17-valerate
Conditions | Yield |
---|---|
With sodium tetrahydroborate; In methanol;
|
979-32-8 Upstream products
-
63042-28-4
estradiol divalerate
-
50-28-2
estradiol
-
109-52-4
valeric acid
-
63042-21-7
3-benzoyloxy-17β-valeryloxy-estra-1,3,5(10)-triene
979-32-8 Downstream products
-
31299-96-4
estradiol-17β 3-β-D-glucopyranoside
Relevant Products
-
Thiobenzoic acidCAS NO.: 98-91-9
CAS:98-91-9
-
Estra-1,3,5(10)-triene-3,17-diol(17b)-
CAS:50-28-2
-
Trimethylolpropane triacrylate
CAS:15625-89-5